Virbac Group, a leading player in the global animal health industry, is headquartered in France and operates extensively across Europe, North America, and Asia. Founded in 1964, the company has established itself as a trusted provider of veterinary products and services, focusing on the health and well-being of companion animals and livestock. Virbac's core offerings include vaccines, pharmaceuticals, and nutritional products, all designed to enhance animal health and productivity. What sets Virbac apart is its commitment to research and development, ensuring innovative solutions tailored to the evolving needs of veterinarians and pet owners alike. With a strong market position, Virbac has achieved notable milestones, including a robust international presence and a diverse product portfolio that reflects its dedication to quality and efficacy in animal care.
How does Virbac group's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Virbac group's score of 31 is higher than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2022, Virbac Group reported total carbon emissions of approximately 23.7 million kg CO2e, all of which were classified under Scope 1 emissions. This figure represents a slight increase from 2021, when emissions were about 20.8 million kg CO2e, also solely from Scope 1. In 2020, the company recorded approximately 21.0 million kg CO2e, again entirely from Scope 1 emissions. The emissions data from 2014 indicates a more comprehensive breakdown, with total emissions of approximately 41.0 million kg CO2e, comprising about 19.2 million kg CO2e from Scope 1, 15.0 million kg CO2e from Scope 2, and 6.8 million kg CO2e from Scope 3. This earlier data highlights the company's evolution in emissions reporting, as it has progressively focused on Scope 1 emissions in recent years. Despite the emissions data available, Virbac Group has not set specific reduction targets or initiatives, as indicated by the absence of documented reduction targets or commitments to frameworks such as the Science Based Targets initiative (SBTi). The company’s climate strategy appears to be in its early stages, with no significant pledges or initiatives currently reported. Overall, Virbac Group's emissions profile reflects a concentrated effort on managing direct emissions, but further commitments and strategies will be essential for addressing broader climate impacts and achieving long-term sustainability goals.
Access structured emissions data, company-specific emission factors, and source documents
| 2014 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|
| Scope 1 | 19,186,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 15,014,000 | - | - | - |
| Scope 3 | 6,818,000 | - | - | - |
Their carbon footprint includes suppliers and value chain emissions, with Scope 3 emissions accounting for 17% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the primary emissions source at 73% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Virbac group has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.